Piper Sandler analyst Allison Bratzel reiterated a Buy rating on IO Biotech (IOBT – Research Report) today and set a price target of $10.00.

Burning Rock Biotech Limited’s BNR share price has dipped by 13.43%, which has investors questioning if this is right time to buy.

The Annual General Meeting will be transmitted to shareholders via webcast on the Shareholder portal, www.bavarian-nordic.com ...

EnnoDC presents positive Phase I data at CROI 2025, demonstrating long-lasting immunity induced by Antibody Mediated Vaccines (AMVs) ...

After hours: March 12 at 4:05:05 PM EDT Loading Chart for IOBT ...

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will meet institutional ...

The biotechnology company intends to more than double its current production capacity at the Navy Yard, interim CEO Fred Vogt ...

UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare ...

Q4 2024 Earnings Call Transcript March 10, 2025 Operator: Welcome to BioNTech’s Fourth Quarter and Full-Year 2024 Earnings ...

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Lean Basketball Analytics (LBA) is excited to unveil its March Madness AI Bracket Calculator ?a free AI-powered tool designed to help fans make smarter picks for this year's NCAA Tournament. Using ...